Article Versions Notes

Nebie I, Palacpac NMQ, Bougouma EC, Diarra A, Ouédraogo A, D’Alessio F, Houard S, Tiono AB, Cousens S, Horii T, et al. Persistence of Anti-SE36 Antibodies Induced by the Malaria Vaccine Candidate BK-SE36/CpG in 5–10-Year-Old Burkinabe Children Naturally Exposed to Malaria. Vaccines. 2024; 12(2):166. https://doi.org/10.3390/vaccines12020166

Nebie, Issa, Nirianne Marie Q. Palacpac, Edith Christiane Bougouma, Amidou Diarra, Alphonse Ouédraogo, Flavia D’Alessio, Sophie Houard, Alfred B. Tiono, Simon Cousens, Toshihiro Horii, and et al. 2024. "Persistence of Anti-SE36 Antibodies Induced by the Malaria Vaccine Candidate BK-SE36/CpG in 5–10-Year-Old Burkinabe Children Naturally Exposed to Malaria" Vaccines 12, no. 2: 166. https://doi.org/10.3390/vaccines12020166

Nebie, I., Palacpac, N. M. Q., Bougouma, E. C., Diarra, A., Ouédraogo, A., D’Alessio, F., Houard, S., Tiono, A. B., Cousens, S., Horii, T., & Sirima, S. B. (2024). Persistence of Anti-SE36 Antibodies Induced by the Malaria Vaccine Candidate BK-SE36/CpG in 5–10-Year-Old Burkinabe Children Naturally Exposed to Malaria. Vaccines, 12(2), 166. https://doi.org/10.3390/vaccines12020166